Drug survival of infliximab and adalimumab in inflammatory bowel disease

被引：0
|
作者：
Asadipour, Erfan [1 ]
Kargar, Mona [2 ]
机构：
[1] Univ Tehran Med Sci, Fac Pharm, Dept Clin Pharm, Tehran, Iran
[2] Univ Tehran Med Sci, Res Ctr Rational Use Drugs, Tehran, Iran
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2020年 / 42卷 / 06期
关键词：
THERAPY;
D O I：
10.1007/s11096-020-01151-9
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1521 / 1523
页数：3
相关论文
共 50 条
  • [31] Adalimumab for the treatment of inflammatory bowel disease
    Wasan, Sharmeel K.
    Kane, Sunanda V.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 5 (06) : 679 - 684
  • [32] Adalimumab in Pediatric Inflammatory Bowel Disease
    Choi, So Yoon
    Kang, Ben
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [33] Adalimumab biosimilar in inflammatory bowel disease
    Fiorino, Gionata
    Allocca, Mariangela
    Danese, Silvio
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (10): : 775 - 776
  • [34] Influence of initial albumin levels on infliximab and adalimumab trough levels in inflammatory bowel disease patients
    Gonzalez-Lopez, J.
    Llamas, C.
    Giraldez-Montero, J. M.
    Ferreiro, R.
    Baston, I.
    Lamas, M. J.
    Dominguez-Munoz, J. E.
    Barreiro-de Acosta, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S248 - S249
  • [35] Adalimumab in childhood inflammatory Bowel disease
    Noc, J. D.
    Pfefferkorn, M. D.
    PEDIATRIC RESEARCH, 2007, 62 (04) : 521 - 521
  • [36] Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars
    Petric, Zvonimir
    Goncalves, Joao
    Paixao, Paulo
    PHARMACEUTICS, 2022, 14 (09)
  • [37] The Effect of Infliximab and Adalimumab Treatment on Angiogenic Factor Levels in Patients With Inflammatory Bowel Disease (IBD)
    Algaba, Alicia
    Linares, Pablo M.
    Contreras, Maria Encarnacion Fernandez
    Figuerola, Ariadna
    Calvet, Xavier
    Guerra, Ivan
    Villa, Jose Carlos
    Chaparro, Maria
    Agullo, Jose Luis Rodriguez
    Gisbert, Javier P.
    Bermejo, Fernando
    GASTROENTEROLOGY, 2012, 142 (05) : S869 - S870
  • [38] Infliximab in paediatric inflammatory bowel disease
    Vilar, Pere
    Martin de Carpi, Javier
    Acuna, Claudia E.
    Luisa Masiques, Ma
    JOURNAL OF CROHNS & COLITIS, 2007, 1 (01): : 2 - 9
  • [39] Infliximab: Use in inflammatory bowel disease
    Travassos W.J.
    Cheifetz A.S.
    Current Treatment Options in Gastroenterology, 2005, 8 (3) : 187 - 196
  • [40] Infliximab/RisankizumabPulmonary inflammatory bowel disease
    Reactions Weekly, 2024, 1996 (1) : 118 - 118
12345